Latest period
$7.12M
YoY change
-73.4%
5Y CAGR
-35.1%
Peak year (2021)
$6.53M
Latest annual
$736.00K
Total Debt history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: $736.00K
Total Debt growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -73.4%
Total Debt history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | $736.00K | -73.4% | −$2.03M | ||
| 2024 | $2.77M | -40.0% | −$1.84M | ||
| 2023 | $4.61M | -27.0% | −$1.71M | ||
| 2022 | $6.32M | -3.3% | −$216.00K | ||
| 2021 | $6.53M | +2.4% | +$153.00K | ||
| 2020 | $6.38M | +43.5% | +$1.93M | ||
| 2019 | $4.45M | — | +$4.45M | ||
| 2018 | $0.00 | — | — |
- 2025$736.00K-73.4%
- 2024$2.77M-40.0%
- 2023$4.61M-27.0%
- 2022$6.32M-3.3%
- 2021$6.53M+2.4%
- 2020$6.38M+43.5%
- 2019$4.45M—
- 2018$0.00—
Total Debt values are taken from Spruce Biosciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's latest reported total debt is $7.12M. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Spruce Biosciences (SPRB) reported total debt of $736.00K – plunged 73.4% year-over-year.
Across 2020–2025 (5 years), Spruce Biosciences total debt produced a CAGR of -35.1% – with a net decline across the window.
The record annual total debt stands at $6.53M, reached in 2021; the historical low of $0.00 was recorded in 2018.
Spruce Biosciences Total Debt by Year
Spruce Biosciences Total Debt 2025: $736.00K
Spruce Biosciences posted total debt of $736.00K in 2025, plunged 73.4% below 2024.
Spruce Biosciences Total Debt 2024: $2.77M
In 2024, Spruce Biosciences reported total debt of $2.77M, plunged 40.0% below 2023.
Spruce Biosciences Total Debt 2023: $4.61M
Spruce Biosciences total debt in 2023 was $4.61M, declined 27.0% below 2022.
Spruce Biosciences Total Debt 2022: $6.32M
2022's total debt for Spruce Biosciences came in at $6.32M, edged down 3.3% below 2021.
Spruce Biosciences Total Debt 2021: $6.53M
Spruce Biosciences total debt in 2021 was $6.53M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Total Debt
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation